Volume 1, Number 1 (March 2015)                   mazums-pbr 2015, 1(1): 1-17 | Back to browse issues page



DOI: 10.18869/acadpub.pbr.1.1.1

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hashemi S M, Emami S. Kojic acid-derived tyrosinase inhibitors: synthesis and bioactivity. mazums-pbr. 2015; 1 (1) :1-17
URL: http://pbr.mazums.ac.ir/article-1-21-en.html

Department of Medicinal Chemistry, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
Abstract:   (2453 Views)

Tyrosinase is a key enzyme for melanin biosynthesis, catalyzing the oxidation of L-tyrosine to L-dopaquinone. The tyrosinase inhibition is an effective approach to control hyperpigmentation in human skin and enzymatic browning in fruits and vegetables. Kojic acid is a naturally-occurring tyrosinase inhibitor which has been clinically used to treat the hyperpigmentation of skin. However, kojic acid as a hydrophilic small-molecule has insufficient inhibitory activity and stability, with considerable toxicity. To overcome these drawbacks, synthetic derivatives of kojic acid were developed, which exhibited enhanced tyrosinase inhibitory activity and more favorable stability relative to kojic acid. In this context, the synthesis and biological activity of kojic acid derivatives as tyrosinase inhibitors have been highlighted.

Full-Text [PDF 567 kb]   (941 Downloads)    
Type of Study: Review | Subject: Medical Chemistry

Add your comments about this article : Your username or email:
Write the security code in the box

© 2015 All Rights Reserved | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb